Home LiteratureArticle Details
PMID: 18218092 Published · epublish English Comparative Study Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Predicting biological system objectives de novo from internal state measurements.

BMC bioinformatics ·Vol. 9 ·2008-01-24 ·Pages 43

Gianchandani EP, Oberhardt MA, Burgard AP, Maranas CD, Papin JA

Abstract

Optimization theory has been applied to complex biological systems to interrogate network properties and develop and refine metabolic engineering strategies. For example, methods are emerging to engineer cells to optimally produce byproducts of commercial value, such as bioethanol, as well as molecular compounds for disease therapy. Flux balance analysis (FBA) is an optimization framework that aids in this interrogation by generating predictions of optimal flux distributions in cellular networks. Critical features of FBA are the definition of a biologically relevant objective function (e.g., maximizing the rate of synthesis of biomass, a unit of measurement of cellular growth) and the subsequent application of linear programming (LP) to identify fluxes through a reaction network. Despite the success of FBA, a central remaining challenge is the definition of a network objective with biological meaning. We present a novel method called Biological Objective Solution Search (BOSS) for the inference of an objective function of a biological system from its underlying network stoichiometry as well as experimentally-measured state variables. Specifically, BOSS identifies a system objective by defining a putative stoichiometric "objective reaction," adding this reaction to the existing set of stoichiometric constraints arising from known interactions within a network, and maximizing the putative objective reaction via LP, all the while minimizing the difference between the resultant in silico flux distribution and available experimental (e.g., isotopomer) flux data. This new approach allows for discovery of objectives with previously unknown stoichiometry, thus extending the biological relevance from earlier methods. We verify our approach on the well-characterized central metabolic network of Saccharomyces cerevisiae. We illustrate how BOSS offers insight into the functional organization of biochemical networks, facilitating the interrogation of cellular design principles and development of cellular engineering applications. Furthermore, we describe how growth is the best-fit objective function for the yeast metabolic network given experimentally-measured fluxes.

MeSH Terms
Computational Biology/methods,trends Forecasting Metabolic Networks and Pathways/physiology Saccharomyces cerevisiae/growth & development,metabolism,physiology Systems Biology/methods,trends
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Gianchandani Erwin P
Department of Biomedical Engineering University of Virginia Box 800759, Health System Charlottesville, VA 22908 USA. [email protected]
Oberhardt Matthew A
Burgard Anthony P
Maranas Costas D
Papin Jason A
References (45)
45 references, click to expand
  1. Stoichiometric interpretation of Escherichia coli glucose catabolism under various oxygenation rates.
    Appl Environ Microbiol. 1993 Aug;59(8):2465-73 PMID: 8368835
  2. Genome-scale models of microbial cells: evaluating the consequences of constraints.
    Nat Rev Microbiol. 2004 Nov;2(11):886-97 PMID: 15494745
  3. Metabolic engineering under uncertainty--II: analysis of yeast metabolism.
    Metab Eng. 2006 Mar;8(2):142-59 PMID: 16413809
  4. Escherichia coli K-12 undergoes adaptive evolution to achieve in silico predicted optimal growth.
    Nature. 2002 Nov 14;420(6912):186-9 PMID: 12432395
  5. Dynamic flux balance analysis of diauxic growth in Escherichia coli.
    Biophys J. 2002 Sep;83(3):1331-40 PMID: 12202358
  6. Multiple knockout analysis of genetic robustness in the yeast metabolic network.
    Nat Genet. 2006 Sep;38(9):993-8 PMID: 16941010
  7. Use of constraint-based modeling for the prediction and validation of antimicrobial targets.
    Biochem Pharmacol. 2006 Mar 30;71(7):1026-35 PMID: 16329998
  8. In silico predictions of Escherichia coli metabolic capabilities are consistent with experimental data.
    Nat Biotechnol. 2001 Feb;19(2):125-30 PMID: 11175725
  9. Stoichiometric flux balance models quantitatively predict growth and metabolic by-product secretion in wild-type Escherichia coli W3110.
    Appl Environ Microbiol. 1994 Oct;60(10):3724-31 PMID: 7986045
  10. Bayesian-based selection of metabolic objective functions.
    Bioinformatics. 2007 Feb 1;23(3):351-7 PMID: 17150997
  11. Metabolic flux responses to pyruvate kinase knockout in Escherichia coli.
    J Bacteriol. 2002 Jan;184(1):152-64 PMID: 11741855
  12. Systematic evaluation of objective functions for predicting intracellular fluxes in Escherichia coli.
    Mol Syst Biol. 2007;3:119 PMID: 17625511
  13. Global organization of metabolic fluxes in the bacterium Escherichia coli.
    Nature. 2004 Feb 26;427(6977):839-43 PMID: 14985762
  14. Network identification and flux quantification in the central metabolism of Saccharomyces cerevisiae under different conditions of glucose repression.
    J Bacteriol. 2001 Feb;183(4):1441-51 PMID: 11157958
  15. Use of genome-scale microbial models for metabolic engineering.
    Curr Opin Biotechnol. 2004 Feb;15(1):64-9 PMID: 15102469
  16. The Escherichia coli MG1655 in silico metabolic genotype: its definition, characteristics, and capabilities.
    Proc Natl Acad Sci U S A. 2000 May 9;97(10):5528-33 PMID: 10805808
  17. Metabolic network structure determines key aspects of functionality and regulation.
    Nature. 2002 Nov 14;420(6912):190-3 PMID: 12432396
  18. Determination of metabolic flux changes during fed-batch cultivation from measurements of intracellular amino acids by LC-MS/MS.
    J Biotechnol. 2007 Jan 30;128(1):93-111 PMID: 17055605
  19. Mathematical models in microbial systems biology.
    Curr Opin Microbiol. 2004 Oct;7(5):513-8 PMID: 15451507
  20. Optimization-based framework for inferring and testing hypothesized metabolic objective functions.
    Biotechnol Bioeng. 2003 Jun 20;82(6):670-7 PMID: 12673766
  21. In silico design and adaptive evolution of Escherichia coli for production of lactic acid.
    Biotechnol Bioeng. 2005 Sep 5;91(5):643-8 PMID: 15962337
  22. Identification of in vivo enzyme activities in the cometabolism of glucose and acetate by Saccharomyces cerevisiae by using 13C-labeled substrates.
    Eukaryot Cell. 2003 Jun;2(3):599-608 PMID: 12796305
  23. Flux-balance analysis of mitochondrial energy metabolism: consequences of systemic stoichiometric constraints.
    Am J Physiol Regul Integr Comp Physiol. 2001 Mar;280(3):R695-704 PMID: 11171647
  24. Integrated analysis of regulatory and metabolic networks reveals novel regulatory mechanisms in Saccharomyces cerevisiae.
    Genome Res. 2006 May;16(5):627-35 PMID: 16606697
  25. Genome-scale thermodynamic analysis of Escherichia coli metabolism.
    Biophys J. 2006 Feb 15;90(4):1453-61 PMID: 16299075
  26. Reconstruction and validation of Saccharomyces cerevisiae iND750, a fully compartmentalized genome-scale metabolic model.
    Genome Res. 2004 Jul;14(7):1298-309 PMID: 15197165
  27. Mathematical analysis of enzymic reaction systems using optimization principles.
    Eur J Biochem. 1991 Oct 1;201(1):1-21 PMID: 1915354
  28. Analysis of optimality in natural and perturbed metabolic networks.
    Proc Natl Acad Sci U S A. 2002 Nov 12;99(23):15112-7 PMID: 12415116
  29. A methodology for the structural and functional analysis of signaling and regulatory networks.
    BMC Bioinformatics. 2006 Feb 07;7:56 PMID: 16464248
  30. Parasite immune escape: new views into host-parasite interactions.
    Curr Opin Microbiol. 2005 Aug;8(4):428-33 PMID: 15993644
  31. Metabolic networks in motion: 13C-based flux analysis.
    Mol Syst Biol. 2006;2:62 PMID: 17102807
  32. Flux balance analysis of mycolic acid pathway: targets for anti-tubercular drugs.
    PLoS Comput Biol. 2005 Oct;1(5):e46 PMID: 16261191
  33. Two approaches for metabolic pathway analysis?
    Trends Biotechnol. 2003 Feb;21(2):64-9 PMID: 12573854
  34. Effect of lpdA gene knockout on the metabolism in Escherichia coli based on enzyme activities, intracellular metabolite concentrations and metabolic flux analysis by 13C-labeling experiments.
    J Biotechnol. 2006 Mar 23;122(2):254-66 PMID: 16310273
  35. Toward a science of metabolic engineering.
    Science. 1991 Jun 21;252(5013):1668-75 PMID: 2047876
  36. Advances in flux balance analysis.
    Curr Opin Biotechnol. 2003 Oct;14(5):491-6 PMID: 14580578
  37. Game-theoretical approaches to studying the evolution of biochemical systems.
    Trends Biochem Sci. 2005 Jan;30(1):20-5 PMID: 15653322
  38. Effect of zwf gene knockout on the metabolism of Escherichia coli grown on glucose or acetate.
    Metab Eng. 2004 Apr;6(2):164-74 PMID: 15113569
  39. FluxAnalyzer: exploring structure, pathways, and flux distributions in metabolic networks on interactive flux maps.
    Bioinformatics. 2003 Jan 22;19(2):261-9 PMID: 12538248
  40. Large-scale 13C-flux analysis reveals mechanistic principles of metabolic network robustness to null mutations in yeast.
    Genome Biol. 2005;6(6):R49 PMID: 15960801
  41. The JAK-STAT signaling network in the human B-cell: an extreme signaling pathway analysis.
    Biophys J. 2004 Jul;87(1):37-46 PMID: 15240442
  42. Robustness analysis of the Escherichia coli metabolic network.
    Biotechnol Prog. 2000 Nov-Dec;16(6):927-39 PMID: 11101318
  43. Production of the antimalarial drug precursor artemisinic acid in engineered yeast.
    Nature. 2006 Apr 13;440(7086):940-3 PMID: 16612385
  44. In silico aided metabolic engineering of Saccharomyces cerevisiae for improved bioethanol production.
    Metab Eng. 2006 Mar;8(2):102-11 PMID: 16289778
  45. Flux balance analysis in the era of metabolomics.
    Brief Bioinform. 2006 Jun;7(2):140-50 PMID: 16772264
Article Info
Journal
BMC bioinformatics
Abbr.
BMC Bioinformatics
ISSN
1471-2105
Published
2008-01-24
Epub
2008-00-24
Pages
43
Language
English
Region
England
NLM ID
100965194
PMCID
PMC2258290
Subset
IM
Grants
NIGMS NIH HHS · T32 GM008715 · United States
NIGMS NIH HHS · GM08715 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]